1. Tallo T，Norder H，Tefanova V，et al. Genetic characterization of hepatitis C virus strains in Estonia：fluctuations in the predominating subtype with time. J Med Virol 2007；79（4）：374-382.

2. Cristina J，Colina R. Evidence of structural genomic region recombination in Hepatitis C virus. Virol J 2006；3：53.

3. Argentini C，Genovese D，Dettori S，et al. HCV genetic variability：from quasispecies evolution to genotype classification. Future Microbiol 2009；4：359-373.

4. Domingo E，Martin V，Perales C，et al. Viruses as quasispecies：biological implications. Curr Top Microbiol Immunol 2006；299：51-82.

5. Munoz de Rueda P，Casado J，Paton R，et al. Mutations in E2-PePHD，NS5A-PKRBD，NS5A-ISDR，and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon- ribavirin treatment responses. J Virol 2008；82（13）：6644-6653.

6. Hofmann WP，Polta A，Herrmann E，et al. Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy. Gastroenterology 2007；132（3）：921-930.

7. Neumann-Haefelin C，Thimme R. Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection. Genes Immun 2007；8（3）：181-192.

8. Strickland GT，El-Kamary SS，Klenerman P，et al. Hepatitis C vaccine：supply and demand. Lancet Infect Dis 2008；8（6）：379-386.

9. Tsai YH，Kuang WF，Lu TY，et al. The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism. J Hepatol 2008；49（6）：899-907.